Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Researchers from University Medical Center report recent findings in cancer gene therapy
September 16th, 2008
New investigation results, 'Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology,' are detailed in a study published in Molecular Cancer Therapeutics. According to recent research from Amsterdam, Netherlands, "The approximately 15-kDa variable domains of camelid heavy-chain-only antibodies (called Nanobodies) can easily be formatted as multivalent or multispecific single-chain proteins. Because of fast excretion, however, they are less suitable for therapy of cancer." "In this study, we aimed for improved tumor targeting of a bivalent anti-epidermal growth factor...
Source: Cancer Weekly (2008-09-16)
|
